Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on October 7, 2008
JNCI Journal of the National Cancer Institute 2008 100(20):1424-1426; doi:10.1093/jnci/djn377
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/20/1424    most recent
djn377v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sharma, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, S. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

NEWS

Media's Influence Extends to Cancer Care

Sharan Prakash Sharma

The first 150 words of the full text of this article appear below.

The media is a major source of cancer information for the public. Although news reports can educate readers about advances in cancer research, the media are often criticized for spreading inaccurate and hyped stories about the disease. Three recent analyses examine whether cancer news coverage in the mainstream media has influenced the policy and practice of cancer care in three different countries.

A report published in the June issue of the Journal of the Royal Society of Medicine revealed how the Australian media's news coverage of trastuzumab, a drug used in HER2-positive breast cancer, affected the government's decision to include the drug in a state-subsidized drug list.

With the publication of the trastuzumab trial results in the New England Journal of Medicine in October 2005, demand for the drug by the media and cancer advocacy groups surged in many countries even though the drug was not yet licensed for treatment. . . . [Full Text of this Article]

Influence on Doctors’ Prescriptions

Covering a Celebrity's Illness

Not Just the Media


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?